Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text PDF (Full Text) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JGP Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cai, Z. Articles by Sheppard, D. N. Search for Related Content PubMed PubMed Citation Articles by Cai, Z. Articles by Sheppard, D. N. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                      What's this?

Department of Physiology, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK

Address correspondence to D.N. Sheppard, Department of Physiology, School of Medical Sciences, University Walk, University of Bristol, Bristol BS8 1TD, UK. Fax: (44) 117 928 8923; email: D.N.Sheppard{at}bristol.ac.uk

When excised inside-out membrane patches are bathed in symmetrical Cl^--rich solutions, the current-voltage (I-V) relationship of macroscopic cystic fibrosis transmembrane conductance regulator (CFTR) Cl^- currents inwardly rectifies at large positive voltages. To investigate the mechanism of inward rectification, we studied CFTR Cl^- channels in excised inside-out membrane patches from cells expressing wild-type human and murine CFTR using voltage-ramp and -step protocols. Using a voltage-ramp protocol, the magnitude of human CFTR Cl^- current at +100 mV was 74 ± 2% (n = 10) of that at -100 mV. This rectification of macroscopic CFTR Cl^- current was reproduced in full by ensemble currents generated by averaging single-channel currents elicited by an identical voltage-ramp protocol. However, using a voltage-step protocol the single-channel current amplitude (i) of human CFTR at +100 mV was 88 ± 2% (n = 10) of that at -100 mV. Based on these data, we hypothesized that voltage might alter the gating behavior of human CFTR. Using linear three-state kinetic schemes, we demonstrated that voltage has marked effects on channel gating. Membrane depolarization decreased both the duration of bursts and the interburst interval, but increased the duration of gaps within bursts. However, because the voltage dependencies of the different rate constants were in opposite directions, voltage was without large effect on the open probability (P_o) of human CFTR. In contrast, the P_o of murine CFTR was decreased markedly at positive voltages, suggesting that the rectification of murine CFTR is stronger than that of human CFTR. We conclude that inward rectification of CFTR is caused by a reduction in i and changes in gating kinetics. We suggest that inward rectification is an intrinsic property of the CFTR Cl^- channel and not the result of pore block.

Key Words: ATP-binding cassette transporter • cystic fibrosis • chloride ion channel • channel gating • voltage dependence

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T.-Y. Chen and T.-C. Hwang CLC-0 and CFTR: Chloride Channels Evolved From Transporters Physiol Rev, April 1, 2008; 88(2): 351 - 387. [Abstract] [Full Text] [PDF]

				R. Robert, G. W. Carlile, C. Pavel, N. Liu, S. M. Anjos, J. Liao, Y. Luo, D. Zhang, D. Y. Thomas, and J. W. Hanrahan Structural Analog of Sildenafil Identified as a Novel Corrector of the F508del-CFTR Trafficking Defect Mol. Pharmacol., February 1, 2008; 73(2): 478 - 489. [Abstract] [Full Text] [PDF]

				C. Routaboul, C. Norez, P. Melin, M.-C. Molina, B. Boucherle, F. Bossard, S. Noel, R. Robert, C. Gauthier, F. Becq, et al. Discovery of {alpha}-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1023 - 1035. [Abstract] [Full Text] [PDF]

				M. Roxo-Rosa, Z. Xu, A. Schmidt, M. Neto, Z. Cai, C. M. Soares, D. N. Sheppard, and M. D. Amaral Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms PNAS, November 21, 2006; 103(47): 17891 - 17896. [Abstract] [Full Text] [PDF]

				C. N. St. Aubin and P. Linsdell Positive Charges at the Intracellular Mouth of the Pore Regulate Anion Conduction in the CFTR Chloride Channel J. Gen. Physiol., November 1, 2006; 128(5): 535 - 545. [Abstract] [Full Text] [PDF]

				L. Csanady, A. C. Nairn, and D. C. Gadsby Thermodynamics of CFTR Channel Gating: A Spreading Conformational Change Initiates an Irreversible Gating Cycle J. Gen. Physiol., November 1, 2006; 128(5): 523 - 533. [Abstract] [Full Text] [PDF]

				Z. Cai, A. Taddei, and D. N. Sheppard Differential Sensitivity of the Cystic Fibrosis (CF)-associated Mutants G551D and G1349D to Potentiators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl- Channel J. Biol. Chem., January 27, 2006; 281(4): 1970 - 1977. [Abstract] [Full Text] [PDF]

				S. G. Bompadre, T. Ai, J. H. Cho, X. Wang, Y. Sohma, M. Li, and T.-C. Hwang CFTR Gating I: Characterization of the ATP-dependent Gating of a Phosphorylation-independent CFTR Channel ({Delta}R-CFTR) J. Gen. Physiol., March 28, 2005; 125(4): 361 - 375. [Abstract] [Full Text] [PDF]

				D. N. Sheppard CFTR Channel Pharmacology: Novel Pore Blockers Identified by High-throughput Screening J. Gen. Physiol., July 26, 2004; 124(2): 109 - 113. [Full Text] [PDF]

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents